IAOTP names Christina DiArcangelo as Top International CEO of 2023

The International Association of Top Professionals (IAOTP) has selected Christina DiArcangelo as the Top International CEO of 2023. She is the Chief Clinical R&D Officer of Spectral Analytics Inc., CEO of Spectral Analytics Precision Tele-Monitoring Inc., CEO and Board President of Affinity Patient Advocacy, CEO and Founder of Affinity Bio Partners, CEO and Co-founder of AI Health Outcomes, CannaBot™.

These special awards are given to those who have done extraordinary services for their communities as well as for their remarkable professional and academic accomplishments, leadership skills, affiliations, and longevity in the field.

IAOTP is an honor and only selected persons in each field can achieve this award. The awards will be provided at the IAOTPs yearly awards Gala at the end of this year.

Stephanie Cirami, the President of IAOTP said that he is honored to have Christina as one of their IAOTP. She is talented and determined. He hoped to meet her at the Annual Gala Awards.

Christina is a seasoned entrepreneur and CEO with over 20 years of experience in medical fields like cannabis, biotechnology, pharmaceutical, nutraceutical, and other medical devices. She also started her podcast channel titled "I am Christina DiArcangelo" where she interacted with influential people. Her clinical devices have been approved by the FDA.

She also received several top awards like Top 29 Women in Medical Cannabis and the 2018 Oxford Who's Who Top Tier of Excellence Lifetime. She received the Top 100 Registry for Business Leaders and Professionals in 2017 and 2018 and many more.